Generali Investments Towarzystwo Funduszy Inwestycyjnych Procept Bio Robotics Corp Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $157 Billion
- Q1 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 16,000 shares of PRCT stock, worth $870,560. This represents 0.59% of its overall portfolio holdings.
Number of Shares
16,000Holding current value
$870,560% of portfolio
0.59%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
292Shares Held
39.9MCall Options Held
196KPut Options Held
142K-
Vanguard Group Inc Valley Forge, PA5.13MShares$279 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$190 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$95.4 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$65.7 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$64.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.43B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...